This is a fact sheet with specific information for a person and/or their support people when starting the open disclosure process. This includes what to expect during the process, how to access support and how to prepare for open disclosure discussions.
This is a short fact sheet about open disclosure and healthcare rights.
The Australian Group on Antimicrobial Resistance (AGAR) monitors AMR, epidemiologic and genetic patterns in bloodstream infections in Australia relating to three main organisms: Staphylococcus aureus, enterococcal species and gram-negative organisms. The 2020 AGAR Sepsis Outcome Programs Report provides analyses of data on AMR associated with episodes of bacteraemia, reported by 30 laboratories servicing 49 public and private institutions across Australia in 2020.
Update 25 provides data submitted to CARAlert for the reporting period 1 September to 31 October 2021 to support prevention and containment of antimicrobial resistance.
The tables below outline the circumstances where it may not be necessary to implement individual actions of the Primary and Community Healthcare Standards.
